Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,421 to 1,440 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| COVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes. | JCI Insight | 2021 | 34143756 | PubTator, text mining | PubMed |
| lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1. | Mol Ther Nucleic Acids | 2021 | 34141461 | PubTator, text mining | PubMed |
| AXL receptor tyrosine kinase: a possible therapeutic target in acute promyelocytic leukemia. | BMC Cancer | 2021 | 34140003 | PubTator, text mining | PubMed |
| AXL Overexpression in Tumor-Derived Endothelial Cells Promotes Vessel Metastasis in Patients With Hepatocellular Carcinoma. | Front Oncol | 2021 | 34123800 | PubTator, text mining | PubMed |
| Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. | Signal Transduct Target Ther | 2021 | 34108441 | PubTator, text mining | PubMed |
| Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study. | Clin Cancer Res | 2021 | 34108184 | PubTator, text mining | PubMed |
| AXL Inhibition in Macrophages Stimulates Host-versus-Leukemia Immunity and Eradicates Naïve and Treatment-Resistant Leukemia. | Cancer Discov | 2021 | 34103328 | PubTator, text mining | PubMed |
| Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network. | PLoS One | 2021 | 34101736 | PubTator, text mining | PubMed |
| Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis. | JCI Insight | 2021 | 34100385 | PubTator, text mining | PubMed |
| Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma. | Cancer Cell | 2021 | 34087162 | PubTator, text mining | PubMed |
| Advances in the treatment of platinum resistant epithelial ovarian cancer: an update on standard and experimental therapies. | Expert Opin Investig Drugs | 2021 | 34082614 | PubTator, text mining | PubMed |
| Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells. | Int J Mol Sci | 2021 | 34073480 | PubTator, text mining | PubMed |
| Microglia in Neurodegenerative Events-An Initiator or a Significant Other? | Int J Mol Sci | 2021 | 34072307 | PubTator, text mining | PubMed |
| Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer. | Cancers (Basel) | 2021 | 34071428 | PubTator, text mining | PubMed |
| Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review. | Cells | 2021 | 34069119 | PubTator, text mining | PubMed |
| In Pursuit of Healthy Aging: Effects of Nutrition on Brain Function. | Int J Mol Sci | 2021 | 34068525 | PubTator, text mining | PubMed |
| Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes. | Cells | 2021 | 34065321 | PubTator, text mining | PubMed |
| Biparatopic single-domain antibodies against Axl achieve ultra-high affinity through intramolecular engagement. | Biochem Biophys Res Commun | 2021 | 34058562 | PubTator, text mining | PubMed |
| Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma. | Aging (Albany NY) | 2021 | 34049287 | PubTator, text mining | PubMed |
| Recent advances in understanding and managing Kallmann syndrome. | Fac Rev | 2021 | 34046641 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=72